 One of these therapies is based on transferring NIS in cancer cells of different origin (breast, colon, prostate...) using adenoviruses or retroviruses (viral vectors).This genetic technique is called gene targeting.Once NIS is transferred in these cells, the patient is treated with radioiodine (131I), being the result a low cancer cell survival rate.